Industries > Pharma > Asia Vaccines Market Forecast to 2029

Asia Vaccines Market Forecast to 2029

Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Influenza, Hepatitis, Polio, Meningococcal, DTP, Rotavirus, MMR, HPV

PUBLISHED: 28 October 2019
PAGES: 178
PRODUCT CODE: PHA0554
SUBMARKET: Regional Markets

Clear
WOOCS 2.2.1
SKU: PHA0554 Categories: , Tags: , ,

Asia vaccines market is estimated at $7bn in 2018 and is expected to grow at a CAGR of 8.8% during the first half of the forecast period. The Japanese vaccines market held 30% share of the Asian vaccines market in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 178-page report you will receive 82 charts– all unavailable elsewhere.

The 178-page report provides clear detailed insight into the Asian vaccines market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Asia Vaccines Market revenue forecasts to 2029

• Asia Vaccines Market revenue forecasts to 2029 by Vaccine Technology:
• Conjugate Vaccines
• Inactivated and Subunit Vaccines
• Live Attenuated Vaccines
• Recombinant Vaccines
• Toxoid Vaccines

• Asia Vaccines Market revenue forecasts to 2029 by Indication:
• Influenza
• Hepatitis
• Polio
• Meningococcal
• DTP
• Rotavirus
• MMR
• HPV
• Others

Please note: The Asia Influenza Vaccines Market has been updated with a range of different economic case scenarios following the global COVID-19 pandemic.

Asia Vaccines Market Forecast to 2029

• Asia Vaccines Market revenue forecasts to 2029 by Country:
• Japan
• China
• India
• Australia
• South Korea
• Vietnam
• Philippines
• Thailand
• Indonesia
• Rest of Asia

Further segmented by indication and vaccine technology.

• Profiles of the selected leading companies:
• Astellas
• AstraZeneca
• CSL, Ltd.
• Emergent BioSolutions, Inc.
• GlaxoSmithKline
• Johnson & Johnson
• Merck
• Mitsubishi Tanabe Pharma Corporation
• Pfizer
• Sanofi
• Serum Institute of India Pvt. Ltd.
• Sun Pharmaceuticals Industries, Ltd.
• Takeda

• This report provides a Pipeline Analysis

• This report discusses factors that drive and restrain the market. This report also discusses trends and opportunities in the market.

• Key Questions Answered by this Report:
• What is the current size of Asia vaccines market? How much will this market be worth from 2018 to 2029?
• What are the main drivers and restraints that will shape Asia vaccines market over the next ten years?
• What are the main segments within Asia vaccines market? How much will each of these segments be worth for the period 2018 to 2029? How will the composition of the market change during that time, and why?
• What factors will affect that industry and market over the next ten years?
• What are the largest national markets for the Asian vaccines market? What is their current status and how will they develop over the next ten years? What are their revenue potentials to 2029?
• Who are the leading companies and what are their activities, results, developments and prospects?

Visiongain’s study is intended for anyone requiring commercial analyses for Asia Vaccines Market. You find data, trends and predictions.

Buy our report today Asia Vaccines Market Forecast to 2029: Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Influenza, Hepatitis, Polio, Meningococcal, DTP, Rotavirus, MMR, HPV.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Asia Vaccines Market Forecast to 2029


Download sample pages

Complete the form below to download your free sample pages for Asia Vaccines Market Forecast to 2029


Latest Pharma news

Visiongain Publishes Generic Drugs Market Report 2020-2030

The 431-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

03 July 2020

READ

Visiongain publishes Clinical Workflow Solutions Market Report 2020-2030

Where is the Clinical Workflow Solutions market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

03 July 2020

READ

Visiongain Publishes Clinical Trials Market Report 2020-2030

With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.

01 July 2020

READ

Visiongain Publishes Clinical Risk Grouping Solutions Market Report 2020-2030

The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.

01 July 2020

READ

Categories